Predisposition of Obesity through Genetic and Non-Genetic Risk Factors

Updata:01-01-1970

Source:
By:Alice Jayapradha Cheekurthy

DOI: https://doi.org/10.30564/jer.v2i2.2767

Abstract:

Globally there is an increase in the number of people affected by obesity.This has increased the count of individuals to double,triple, and even quadruple. Obesity is a complex disease that has a genetic, behavioural,socioeconomic, and environmental effect. This raises morbidity and mortality in obesity. It is an important predisposition for diabetes as well as the current pandemic COVID-19. The rationale of this case-control observational study is to identify obese individuals among the diabetic and non-diabetic population. The study includes non - genetic factors like lipid profiles with genetic factors in form of SNP as a predisposition factor. The amplified portion of the ADIPOQ gene sequence revealed the presence of SNPs rs2241767 in 46.3% population and showed increased lipid profile values. It can be concluded that these are important predisposing factors for obesity.

References:

[1] World Health Organization Fact sheet: obesity and overweight. Available online: Accessed on 8.12.2020. [2]Alice JayaPradha Cheekurthy, C Rambabu, Amit Kumar, Gene as a risk factor for type 2 diabetes mellitus and its related complications, Biomed Res Clin Prac, 2016, 1(1):14-17;2016.DOI:10.15761/BRCP.1000104 [3]https://www.idf.org/aboutdiabetes/what-is-diabetes.assessed on 8.12.2020 [4]Matharoo K, Arora P, Bhanwer AJ. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab.Gene,2013, 527: 228-234. [Crossref] [5]Takahashi M, Arita Y, Yamagata K, Matsukawa Y,Okutomi K, Horie M, Shimomura I, Hotta K,Kuriyama H, Kihara S, Nakamura T, Yamashita Seigo,Funahashi Tohru, Matsuzawa Yuji. Genomic structure and mutations in the adipose-specific gene, adiponectin. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 2000, 24. 861-8.10.1038/SJ.ijo.0801244. Chu H, Wang M, Zhong D,Shi D, Ma L, et al. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab Res Rev., 2013, 29:532-545. [6]Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity, and serum adiponectin levels in south Indian population. Gene, 2013, 532: 253-262. [7]Gordon T, Castelli WP, Hjortland MC, Kannel WB,Dawber TR. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women.The Framingham study. Ann Intern Med., 1977,87:393-397. [8] Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a eta-analysis.Am J Med., 2006, 119: 812-819. [9] Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab.,2007,92: 399- 404. [10] Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual, (4TH end), CSH Laboratory Press, Cold Spring Harbor, New York, USA, 2001. [11] Subbarayan PR, Sarkar M, Ardalan B. Isolation of Genomic DNA from Human Whole Blood.BioTechniques, 2002, 33: 1231-1234. [12] Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase chain reaction.Methods Enzymol., 1987, 55: 335-350. [13] Johnson PH, Grossman LI. Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double- and single-stranded DNAs.Biochemistry, 1977, 16: 4217-4225. [14] Sanger F, Nicklen S, Coulson AR. Biochemistry DNA sequencing with chain-terminating inhibitors Proc Nati Acad Sci USA, 1977, 74: 5463-546. [15] Brown WV, Fujioka K, Wilson PW, Woodworth KA.Obesity: why be concerned? Am. J. Med.,2009, 122:S4-11. [16] Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 2009,9: 88. [17] Hainer V, Kunesová M, Parízková J, Stunkard A.Health risks and economic costs associated with obesity requiring a comprehensive weight reduction program Cas Lek Cesk. 1997, 136(12): 367-72. [18] W Virgil Brown, Ken Fujioka, Peter WF Wilson, Kristina A Woodworth, Obesity: why be concerned? Am J Med, 2009, 122(4 Suppl 1): S4-11.DOI: 10.1016/j.amjmed.2009.01.002 [19] Srivastava, Neena, Lakhan, Ram & Mittal, Balraj.Pathophysiology and genetics of obesity. Indian journal of experimental biology, 2007, 45: 929-36. [20] Muller-Riemenschneider F, Reinhold T, Berghofer A,Willich SN. Health-economic burden of obesity in Europe. Eur. J. Epidemiol., 2008, 23: 499-509. [21] Bouchard C. Current understanding of the etiology of obesity: genetic and nongenetic factors. Am J Clin Nutr. 1991. 53(6 Suppl): 1561S-1565S.DOI: 10.1093/an/53.6.1561S. PMID: 2031488. [22] Kolovou GD, Anagnostopoulou KK, Cokkinos DV Pathophysiology of dyslipidemia in the metabolic.syndromePostgraduate Medical Journal, 2005, 81:358-366.

Tags: